← Eichor
Study identifier: NCT05159856 Synced from ClinicalTrials.gov · July 28, 2026
● Recruiting

Early Detection of Long-term Diabetic Complications in Children and Adolescents With Type 1 Diabetes

Condition: Diabetes Complications · type1diabetes · Children, Only  ·  Sponsor: Steno Diabetes Center Copenhagen

PhaseN/A
Planned participants400
Who can joinAll sexes, 6 Years to 18 Years
Healthy volunteersNo

About this study

Aims: To investigate early markers of long-term diabetic complications and the association to an extended glucose metabolic profile comprising glucose control (current and past), glucose variability and insulin sensitivity in children and adolescents with type 1 diabetes (T1D). Background: Most Danish children and adolescents with T1D do not achieve their metabolic target and are at increased risk of developing long-term diabetic complications, reducing their life expectancy and increase their morbidity rate. Hence, improved metabolic control, a better understanding of what optimal metabolic control means, combined with detailed monitoring of the first markers of long-term complications and their reversibility or lack thereof are needed. Methods: A prospectivel study of 400 children, aged 6-18 years old, with T1D\>12 months. Early markers of long-term diabetic complications will be investigated as arterial stiffness, nerve dysfunction and nephropathy. Data on T1D onset, duration, treatment modality, self-monitoring-blood-glucose profiles, growth, weight, and pubertal status will be collected. Blood sampling will include routine tests and markers of glucose, lipid, bone, and gastrointestinal metabolism. DXA-scan, Fibroscan, bone-age, eye-examination and physical activity will be measured. Data on retrospective glucose- and lipid-profiles will be collected. The children will be offered a followup every 5 years for the next two decades. Perspectives: This study provides nove…

This description comes directly from the study's public registry record.

Talk to the study team

Julie A Damm, MD  ·  +4527287020  ·  julie.agner.damm.02@regionh.dk

Always discuss trial participation with your own doctor first.

Locations (1)

Steno Diabetes Center CopenhagenHerlev, Herlev, DenmarkRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT05159856